WE-PHARMA

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 288288.87,
      "delta_eur": 288288.87,
      "before_eur": 0.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "BRUSSELAERS Vincent",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 110700,
          "contribution_amount_eur": 100000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "DRION Charles-Antoine",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 110700,
          "contribution_amount_eur": 100000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "BUNKENS Geert",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 38577,
          "contribution_amount_eur": 34848.41
        },
        {
          "kbo": "0873.531.619",
          "rrn": null,
          "kind": "org",
          "name": "CH INVEST",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 59158,
          "contribution_amount_eur": 53440.46
        }
      ],
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": "D",
        "n_new_shares": 319135,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 288288.87,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Didier NELLESSEN",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Huy",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-04-15",
    "filing_date": "2026-04-13",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2026-04-02",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Christophe REMON"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sandrine LUCAS",
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition de l\u2019acte",
    "coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "BRUSSELAERS Vincent",
      "role": "aandeelhouder",
      "n_shares": 110700,
      "share_class": "D"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "DRION Charles-Antoine",
      "role": "aandeelhouder",
      "n_shares": 110700,
      "share_class": "D"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "BUNKENS Geert",
      "role": "aandeelhouder",
      "n_shares": 38577,
      "share_class": "D"
    },
    {
      "kbo": "0873.531.619",
      "pct": null,
      "kind": "org",
      "name": "CH INVEST",
      "role": "aandeelhouder",
      "n_shares": 59158,
      "share_class": "D"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 69839,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 575687,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 193746,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 1919897,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.03
    },
    {
      "n_shares": 586168,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.02
    },
    {
      "n_shares": 1557989,
      "class_name": "F",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.01
    }
  ]
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-12-23",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "l\u2019autre justificatif de l\u2019int\u00E9r\u00EAt des apports pour la soci\u00E9t\u00E9, \u00E9tablis conform\u00E9ment aux articles 5 :121 \u00A71er et 5 :133 du Code des Soci\u00E9t\u00E9s et des Associations. ... Le rapport de Monsieur REMON, conclut dans les termes suivants : ... pour laquelle j\u2019ai \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 17 novembre 2025.",
    "firm_kbo": null,
    "firm_name": "REMON \u0026 CO, R\u00E9viseurs d\u2019Entreprises",
    "ibr_number": null,
    "individual_name": "REMON Christophe"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire d\u00E9cide \u00E9galement de charger le Notaire instrumentant de la coordination des statuts.",
      "holder_kbo": null,
      "holder_name": "Notaire instrumentant",
      "scope_categories": [
        "coordination des statuts"
      ],
      "with_substitution": false
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 695064,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 695064,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-30",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter les apports disponibles en soci\u00E9t\u00E9, \u00E0 concurrence de six cent nonante-cinq mille soixante-quatre euros (695.064 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-03-10",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 575000,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 575000,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-11-04",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter les apports disponibles en soci\u00E9t\u00E9, \u00E0 concurrence de CINQ CENT SEPTANTE-CINQ MILLE euros (575.000 EUR), par la cr\u00E9ation de onze mille huit cent soixante-quatre (11.864) nouvelles actions... L\u2019assembl\u00E9e g\u00E9n\u00E9rale pr\u00E9cise que la totalit\u00E9 de l\u2019apport suppl\u00E9mentaire en num\u00E9raire est affect\u00E9 au compte \u00AB capitaux propres \u00BB disponible.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-05-31",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-02-02",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SPRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Comt\u00E9",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e accepte la d\u00E9mission de Mesdames Comt\u00E9 et G\u00E9rard de leur poste de g\u00E9rante avec effet au 20 juillet prochain.",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "G\u00E9rard",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e accepte la d\u00E9mission de Mesdames Comt\u00E9 et G\u00E9rard de leur poste de g\u00E9rante avec effet au 20 juillet prochain.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Lucas Sandrine",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Sagafil SNC",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "L\u0027assembl\u00E9e nomme au poste de g\u00E9rante la soci\u00E9t\u00E9 Sagafil SNC, repr\u00E9sent\u00E9e par sa g\u00E9rante, Madame Sandrine Lucas, cette nomination prendra \u00E9galement effet au 20 juillet prochain."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SPRL"
  }
}